Clinical Trials Directory

Trials / Completed

CompletedNCT04807322

Reverse Total Shoulder Arthroplasty in Patients Who Exceeded Their Life-expectancy: a Retrospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
110 (actual)
Sponsor
Bürgerspital Solothurn · Academic / Other
Sex
All
Age
83 Years
Healthy volunteers
Accepted

Summary

Reverse total shoulder arthroplasty (RTSA) has become an established treatment for cuff arthropathy, severe osteoarthritis and in certain fracture cases. Due to the increasingly aging population, patients who have already exceeded their life-expectancy pose a significant challenge to the shoulder surgeon. Therefore, we wanted to investigate patient demographics, hospital stay length, complication rate functional outcome, patient reported outcome scores and mortality retrospectively for patients, who were older than 83 years at time of implantation of a RTSA.

Detailed description

This is a retrospective single institution study. All patients older than 83 years who received a reverse shoulder arthroplasty from 2008 until 2019 are included. Elective cases are compared to fracture cases (patient demographics, length of hospital stay, complication rate, functional outcome, patient reported outcome scores and mortality).

Conditions

Interventions

TypeNameDescription
PROCEDUREReverse Total Shoulder Arthroplasty (RTSA)Implantation of a Reverse Total Shoulder Arthroplasty

Timeline

Start date
2019-03-24
Primary completion
2020-08-04
Completion
2020-12-21
First posted
2021-03-19
Last updated
2021-03-19

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04807322. Inclusion in this directory is not an endorsement.